{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T23:31:29Z","timestamp":1785540689350,"version":"3.56.0"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.00493","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T05:41:07Z","timestamp":1596174067000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":54,"title":["Bone Mineral Density in Adults With Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"11","author":[{"given":"Swetha","family":"Rangaswamaiah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Gangathimmaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nordenstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Falhammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s12020-011-9591-x","article-title":"Clinical outcomes in the management of congenital adrenal hyperplasia","volume":"41","author":"Falhammar","year":"2012","journal-title":"Endocrine."},{"key":"B2","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"key":"B3","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1210\/jc.2010-0917","article-title":"Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients","volume":"95","author":"Arlt","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/S0140-6736(17)31431-9","article-title":"Congenital adrenal hyperplasia","volume":"390","author":"El-Maouche","year":"2017","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S2213-8587(13)70007-X","article-title":"One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study","volume":"1","author":"Gidlof","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s12020-018-01835-3","article-title":"Clinical perspectives in congenital adrenal hyperplasia due to 3beta-hydroxysteroid dehydrogenase type 2 deficiency","volume":"63","author":"Al Alawi","year":"2019","journal-title":"Endocrine."},{"key":"B7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12020-016-1189-x","article-title":"Clinical perspectives in congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency","volume":"55","author":"Bulsari","year":"2017","journal-title":"Endocrine."},{"key":"B8","doi-asserted-by":"publisher","first-page":"dgz255","DOI":"10.1210\/clinem\/dgz255","article-title":"P450 oxidoreductase deficiency: a systematic review and meta-analysis of genotypes, phenotypes and their relationships","volume":"105","author":"Dean","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"R127","DOI":"10.1530\/EJE-18-0712","article-title":"Management of endocrine disease: diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency","volume":"180","author":"Nordenstrom","year":"2018","journal-title":"Eur J Endocrinol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/gim.2017.46","article-title":"Revisiting the prevalence of nonclassic congenital adrenal hyperplasia in US Ashkenazi jews and caucasians","volume":"19","author":"Hannah-Shmouni","year":"2017","journal-title":"Genet Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1210\/jc.2006-1350","article-title":"Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"92","author":"Falhammar","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1210\/JC.2015-2093","article-title":"Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedish population-based national cohort study","volume":"100","author":"Falhammar","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","article-title":"Use of oral corticosteroids and risk of fractures","volume":"15","author":"Van Staa","year":"2000","journal-title":"J Bone Miner Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis","volume":"13","author":"van Staa","year":"2002","journal-title":"Osteoporos Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/jbmr.5650110516","article-title":"Altered trabecular architecture induced by corticosteroids: a bone histomorphometric study","volume":"11","author":"Chappard","year":"1996","journal-title":"J Bone Miner Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1359\/jbmr.2001.16.1.97","article-title":"Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis","volume":"16","author":"Dalle Carbonare","year":"2001","journal-title":"J Bone Miner Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"J Clin Invest."},{"key":"B18","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1359\/jbmr.1997.12.3.464","article-title":"Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro","volume":"12","author":"Kasperk","year":"1997","journal-title":"J Bone Miner Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/cen.12507","article-title":"Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"82","author":"El-Maouche","year":"2015","journal-title":"Clin Endocrinol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1080\/07435809509030471","article-title":"Blunted adrenarche in patients with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"21","author":"Sellers","year":"1995","journal-title":"Endocr Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1210\/jcem.82.12.4320","article-title":"The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia","volume":"82","author":"Girgis","year":"1997","journal-title":"J Clin Endocrinol Metab."},{"key":"B22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1515\/JPEM.2007.20.2.227","article-title":"Bone mineral status in children with congenital adrenal hyperplasia","volume":"20","author":"Fleischman","year":"2007","journal-title":"J Pediatr Endocrinol Metab."},{"key":"B23","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1046\/j.1365-2265.1996.00851.x","article-title":"Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia","volume":"45","author":"Guo","year":"1996","journal-title":"Clin Endocrinol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/8756-3282(96)00003-8","article-title":"Bone density in young patients with congenital adrenal hyperplasia","volume":"18","author":"Mora","year":"1996","journal-title":"Bone."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1210\/jc.2002-021074","article-title":"Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia","volume":"88","author":"Stikkelbroeck","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"B26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000075588","article-title":"Normal bone mineral content in young adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"61","author":"Christiansen","year":"2004","journal-title":"Horm Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1542\/peds.100.4.671","article-title":"Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia","volume":"100","author":"Gussinye","year":"1997","journal-title":"Pediatrics."},{"key":"B28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1365-2265.2008.03518.x","article-title":"Bone mineral density and bone turnover in romanian children and young adults with classical 21-hydroxylase deficiency are influenced by glucocorticoid replacement therapy","volume":"71","author":"Zimmermann","year":"2009","journal-title":"Clin Endocrinol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1210\/jcem.80.7.7608286","article-title":"Bone mineral density and body composition in congenital adrenal hyperplasia","volume":"80","author":"Cameron","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"key":"B30","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s00774-003-0434-6","article-title":"Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross-sectional study of factors involved in bone mineral density","volume":"21","author":"de Almeida Freire","year":"2003","journal-title":"J Bone Miner Metab"},{"key":"B31","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000053253","article-title":"Height, bone mineral density and bone markers in congenital adrenal hyperplasia","volume":"54","author":"Paganini","year":"2000","journal-title":"Horm Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1046\/j.1365-2265.1996.8620871.x","article-title":"Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency","volume":"45","author":"Jaaskelainen","year":"1996","journal-title":"Clin Endocrinol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1530\/eje.0.1430667","article-title":"Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy","volume":"143","author":"Hagenfeldt","year":"2000","journal-title":"Eur J Endocrinol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1210\/jc.2005-2823","article-title":"Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency","volume":"91","author":"Sciannamblo","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"B35","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1210\/jc.2005-0745","article-title":"Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia","volume":"91","author":"King","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"B36","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1210\/jc.2007-0744","article-title":"Fractures and bone mineral density in adult women with 21-hydroxylase deficiency","volume":"92","author":"Falhammar","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"B37","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1530\/EJE-12-0865","article-title":"Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia","volume":"168","author":"Falhammar","year":"2013","journal-title":"Eur J Endocrinol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000098017","article-title":"Long-term outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"67","author":"Bachelot","year":"2007","journal-title":"Horm Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1210\/jc.2011-2036","article-title":"Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy","volume":"97","author":"Koetz","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"B40","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1530\/EJE-12-0196","article-title":"Genetic, anthropometric and metabolic features of adult Norwegian patients with 21-hydroxylase deficiency","volume":"167","author":"Nermoen","year":"2012","journal-title":"Eur J Endocrinol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1210\/jc.2012-2102","article-title":"Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia","volume":"97","author":"Finkielstain","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"B42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1530\/EJE-16-0104","article-title":"Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"175","author":"Ceccato","year":"2016","journal-title":"Eur J Endocrinol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4103\/2230-8210.172283","article-title":"Bone mineral density in young adult women with congenital adrenal hyperplasia","volume":"20","author":"Raizada","year":"2016","journal-title":"Indian J Endocrinol Metab."},{"key":"B44","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/cen.14149","article-title":"Bone mineral density and fractures in congenital adrenal hyperplasia: findings from the dsd-LIFE study","volume":"92","author":"Riehl","year":"2019","journal-title":"Clin Endocrinol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1053\/meta.2001.21678","article-title":"Preliminary report: effect of adrenal androgen and estrogen on bone maturation and bone mineral density","volume":"50","author":"Arisaka","year":"2001","journal-title":"Metabolism."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"B47","unstructured":"The Newcastle-ottawa scale (nos) for assessing the quality of nonrandomised studies in meta-analyses\n            Wells GASB\n            O'ConnellD\n            PetersonJ\n            WelchV\n            LososM\n            TugwellP\n          236588502019"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e016777","DOI":"10.1136\/bmjopen-2017-016777","article-title":"The importance of maternal diet quality during pregnancy on cognitive and behavioural outcomes in children: a systematic review and meta-analysis","volume":"7","author":"Borge","year":"2017","journal-title":"BMJ Open."},{"key":"B49","unstructured":"Sch\u00fcnemannH\n            Bro\u017cekJ\n            GuyattG\n            OxmanA\n          GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations. Updated October (2013)2013"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e8933","DOI":"10.1371\/journal.pone.0008933","article-title":"The average body surface area of adult cancer patients in the UK: a multicentre retrospective study","volume":"5","author":"Sacco","year":"2010","journal-title":"PLoS ONE."},{"key":"B51","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/joim.12717","article-title":"Body size and risk of atrial fibrillation: a cohort study of 1.1 million young men","volume":"283","author":"Andersen","year":"2018","journal-title":"J Intern Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1210\/jcem.83.4.4694","article-title":"The daily cortisol production reinvestigated in healthy men. The serum and urinary cortisol production rates are not significantly different","volume":"83","author":"Kraan","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1002\/jbmr.111","article-title":"Bone density, geometry, microstructure, and stiffness: relationships between peripheral and central skeletal sites assessed by DXA, HR-pQCT, and cQCT in premenopausal women","volume":"25","author":"Liu","year":"2010","journal-title":"J Bone Miner Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1210\/jc.2010-2699","article-title":"Final adult height in children with congenital adrenal hyperplasia treated with growth hormone","volume":"96","author":"Lin-Su","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1210\/jc.2006-2109","article-title":"Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty","volume":"92","author":"Bonfig","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"B56","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1210\/er.21.3.245","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"21","author":"White","year":"2000","journal-title":"Endocr Rev."},{"key":"B57","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1365-2265.2009.03606.x","article-title":"Hormonal determinants of bone turnover before and after attainment of peak bone mass","volume":"72","author":"Walsh","year":"2010","journal-title":"Clin Endocrinol."},{"key":"B58","first-page":"15","article-title":"Androgens and the skeleton","volume":"30","author":"Lindberg","year":"2005","journal-title":"Minerva Endocrinol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos Int."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1210\/jc.2009-0636","article-title":"Gender role behavior, sexuality, and psychosocial adaptation in women with congenital adrenal hyperplasia due to CYP21A2 deficiency","volume":"94","author":"Frisen","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"B61","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12020-013-0161-2","article-title":"Quality of life, social situation, and sexual satisfaction, in adult males with congenital adrenal hyperplasia","volume":"47","author":"Falhammar","year":"2014","journal-title":"Endocrine."},{"key":"B62","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1530\/EC-18-0031","article-title":"Health status in 1040 adults with disorders of sex development (DSD): a European multicenter study","volume":"7","author":"Falhammar","year":"2018","journal-title":"Endocr Connect."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00493\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T05:41:13Z","timestamp":1596174073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00493\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,31]]},"references-count":62,"alternative-id":["10.3389\/fendo.2020.00493"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.00493","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,31]]},"article-number":"493"}}